Marketing Authorization Application Submitted to the EMA for Novel Lupus Nephritis Therapy
source: pixabay.com

Marketing Authorization Application Submitted to the EMA for Novel Lupus Nephritis Therapy

Aurinia Pharmaceuticals has just announced that Otsuka Pharmaceutical Europe Ltd. (OPEL), their licensing partner, has just filed a Marketing Authorization Application for an investigative therapy for lupus nephritis (LN) called…

Continue Reading Marketing Authorization Application Submitted to the EMA for Novel Lupus Nephritis Therapy
Benlysta Approved in Europe for Lupus Nephritis
https://pixabay.com/photos/hospital-infusion-hand-association-834157/

Benlysta Approved in Europe for Lupus Nephritis

  In early May 2021, pharmaceutical company GlaxoSmithKline shared that its therapy Benlysta (belimumab) was approved by the European Commission (EC) for expanded use in adult patients with lupus nephritis…

Continue Reading Benlysta Approved in Europe for Lupus Nephritis
Unmet Needs in the Treatment of Certain Glomerular Diseases
source: pixabay.com

Unmet Needs in the Treatment of Certain Glomerular Diseases

by Lauren Taylor from In The Cloud Copy Nephrologists worldwide have shown that there is a huge unmet need when it comes to the treatment of various glomerular diseases, in…

Continue Reading Unmet Needs in the Treatment of Certain Glomerular Diseases
Study Provides Evidence That Lupus Nephritis Seemingly Doesn’t Increase Chances of Severe Infection
source: pixabay.com

Study Provides Evidence That Lupus Nephritis Seemingly Doesn’t Increase Chances of Severe Infection

by Danielle Bradshaw from In The Cloud Copy Research that has recently been made available reveals that lupus nephritis - a kind of kidney disease that’s related to lupus -…

Continue Reading Study Provides Evidence That Lupus Nephritis Seemingly Doesn’t Increase Chances of Severe Infection
ACR Convergence 2020: Presentations on KZR-616 for Autoimmune Conditions
https://pixabay.com/photos/student-typing-keyboard-text-woman-849822/

ACR Convergence 2020: Presentations on KZR-616 for Autoimmune Conditions

Since the company was founded, biotechnology company Kezar Life Sciences ("Kezar") has worked to develop therapies for patients with oncologic and autoimmune disorders. Recently, they highlighted a potential treatment, KZR-616,…

Continue Reading ACR Convergence 2020: Presentations on KZR-616 for Autoimmune Conditions
Meta Analysis Shows MMF Provides Greater Benefit to Lupus Nephritis Patients Than CYC
source: pixabay.com

Meta Analysis Shows MMF Provides Greater Benefit to Lupus Nephritis Patients Than CYC

A recent study, published in the journal Medicine, has found that Mycopheenolate mofetil (MMF) could be a more advantageous therapy for lupus nephritis than cyclophosphamide (CYC) when it comes to improving serum complement…

Continue Reading Meta Analysis Shows MMF Provides Greater Benefit to Lupus Nephritis Patients Than CYC
Safe Pregnancies with Rheumatic Diseases are Possible with Planning
source: pixabay.com

Safe Pregnancies with Rheumatic Diseases are Possible with Planning

Dr. Lisa Sammaritano from Weill Cornell Medical College has explained a way to lower risks within pregnancy for those with rheumatic diseases. Pregnancy and Rheumatic Diseases Patients who have a…

Continue Reading Safe Pregnancies with Rheumatic Diseases are Possible with Planning
Belimumab is the Second Drug to be Developed for Lupus in Over Fifty Years
source: pixabay.com

Belimumab is the Second Drug to be Developed for Lupus in Over Fifty Years

  Dr. Richard Furie at New York’s Feinstein Institutes recently interviewed with MedPage Today. Dr. Furie discussed the prognosis for lupus nephritis and belimumab (Benlysta), a recently-tested drug that appears…

Continue Reading Belimumab is the Second Drug to be Developed for Lupus in Over Fifty Years
This Criteria Helps Predict Chronic Kidney Disease in Lupus Nephritis Patients
source: pixabay.com

This Criteria Helps Predict Chronic Kidney Disease in Lupus Nephritis Patients

Lupus nephritis causes kidney inflammation and can often lead to chronic kidney disease (CKD). An issue that medical professionals have faced is predicting the likelihood of individual patients developing CKD.…

Continue Reading This Criteria Helps Predict Chronic Kidney Disease in Lupus Nephritis Patients
Lupus Nephritis Biomarkers Highlight Race-Based Differences
https://pixabay.com/en/hand-united-together-people-unity-1917895/

Lupus Nephritis Biomarkers Highlight Race-Based Differences

When studying biomarkers of lupus nephritis, researchers at the University of Houston discovered something interesting: race-based differences. Biomarkers are some sort of measurable substance; in this case, urinary proteins. However,…

Continue Reading Lupus Nephritis Biomarkers Highlight Race-Based Differences